HealthLynked Corp.

HLYK

CIK 0001680139 ยท Quarterly mode ยท latest period FY2025 (Q4) (ending 2025-12-31) ยท sourced from SEC EDGAR

At a glance ยท FY2025 (Q4)

Revenue
$310K
โ†“-49.9% -$309Kvs FY2024 (Q4)
Gross Profit
$310K
โ†“-49.9% -$309Kvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot ยท latest annual filed values ยท S&P 500 calibration

Average
63/100
  • Profitability
    100ROIC 29.8% (10% = solid, 20%+ = moat)
  • Liquidity
    0Current Ratio 0.22 (above 1.5 = solid)
  • Leverage
    99D/E 0.02 (under 0.5 = conservative)
  • Efficiency
    76Asset Turnover 1.19x (1.0+ = capital-efficient)
  • Growth
    0Revenue YoY -49.9% (10% = solid, 25%+ = elite)
  • Margin Trend
    100Op Margin -136.3% ยท trend +82.3pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

Capital allocation ยท trailing 4 quarters

how the company spent its cash
Capex (TTM)
โ€”
investment in PP&E
Stock buybacks (TTM)
โ€”
share count reduction
Stock-based comp (TTM)
$159K
non-cash dilution

Balance sheet ยท 2025-12-31

latest filed snapshot
Total assets
$2M
everything owned
Total liabilities
$7M
everything owed
Stockholders' equity
$-6M
shareholder claim
Net debt
$364
LT debt minus cash

Recent performance ยท 40 quarters

Revenueโ†“-49.9% -$309K
$310K
Net Incomeโ†‘+56.8% +$1M
$-852K
Free Cash Flow
$-433K
Operating Marginโ†‘+146.9pts
-136.3%

Drill down